PCSK9 (Bococizumab Biosimilar) anticorps
Research Grade
Reactivité: Humain
FACS
Hôte: Humanized
Monoclonal
unconjugated
-
- Antigène Tous les produits PCSK9 (Bococizumab Biosimilar)
- PCSK9 (Bococizumab Biosimilar)
- Reactivité
- Humain
-
Hôte
-
Humanized
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp PCSK9 (Bococizumab Biosimilar) est non-conjugé
- Application
- Flow Cytometry (FACS)
- Fonction
- Anti-PCSK9 (Bococizumab biosimilar) mAb
- Attributs du produit
- PF-04950615, RN-316, RN316
- Purification
- Purified from cell culture supernatant by affinity chromatography
- Classe de qualité
- Research Grade
- Isotype
- IgG2
-
-
- Indications d'application
- Flow Cyt 1:100
- Commentaires
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Reconstitute with deionized water
- Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
- Date de péremption
- 12 months
-
- Antigène
- PCSK9 (Bococizumab Biosimilar)
- Abstract
- PCSK9 (Bococizumab Biosimilar) Produits
- Classe de substances
- Biosimilar
- Sujet
- FH3, FHCL3, HCHOLA3, LDLCQ1, NARC-1, NARC1, PC9
- UniProt
- Q8NBP7
-
Vous êtes ici:
